GETINGE Revenue 2016-2024 | GNGBY

GETINGE revenue from 2016 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
GETINGE Annual Revenue
(Millions of US $)
2023 $3,001
2022 $2,804
2021 $3,154
2020 $3,250
2019 $2,810
2018 $2,782
2017 $2,639
2016 $3,478
2015 $3,586
GETINGE Quarterly Revenue
(Millions of US $)
2024-09-30 $756
2024-06-30 $797
2024-03-31 $722
2023-12-31 $933
2023-09-30 $704
2023-06-30 $682
2023-03-31 $683
2022-12-31 $805
2022-09-30 $659
2022-06-30 $678
2022-03-31 $662
2021-12-31 $906
2021-09-30 $730
2021-06-30 $783
2021-03-31 $735
2020-12-31 $1,005
2020-09-30 $900
2020-06-30 $721
2020-03-31 $625
2019-12-31 $888
2019-09-30 $651
2019-06-30 $665
2019-03-31 $605
2018-12-31 $884
2018-09-30 $635
2018-06-30 $662
2018-03-31 $601
2017-12-31 $245
2017-09-30 $824
2017-06-30 $823
2017-03-31 $747
2016-12-31 $1,066
2016-09-30 $813
2016-06-30 $844
2016-03-31 $755
2015-12-31 $1,107
Sector Industry Market Cap Revenue
Medical Medical Services $0.000B $3.000B
Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $85.533B 10.61
Cencora (COR) United States $43.432B 16.33
DiDi Global (DIDIY) China $21.921B 0.00
Natera (NTRA) United States $20.932B 0.00
ICON (ICLR) Ireland $17.294B 15.40
Viatris (VTRS) United States $14.777B 4.55
Avantor (AVTR) United States $14.347B 21.51
Revvity (RVTY) United States $13.547B 23.53
BioMerieux (BMXMF) France $12.569B 0.00
CochLear (CHEOY) Australia $12.055B 0.00
Solventum (SOLV) United States $11.410B 0.00
Medpace Holdings (MEDP) United States $10.361B 29.19
Doximity (DOCS) United States $9.981B 58.75
Charles River Laboratories (CRL) United States $9.379B 18.12
HealthEquity (HQY) United States $8.392B 42.10
Sonic Healthcare (SKHHY) Australia $8.061B 0.00
Bausch + Lomb (BLCO) Canada $6.265B 29.16
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.784B 20.24
Organon (OGN) United States $3.770B 3.80
BrightSpring Health Services (BTSG) United States $2.962B 63.00
Surgery Partners (SGRY) United States $2.615B 29.81
Concentras Parent (CON) United States $2.561B 0.00
Ardent Health Partners (ARDT) United States $2.374B 0.00
Alignment Healthcare (ALHC) United States $2.139B 0.00
GeneDx Holdings (WGS) United States $2.104B 0.00
Premier (PINC) United States $2.038B 10.60
PACS (PACS) United States $1.952B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.778B 0.00
GoodRx Holdings (GDRX) United States $1.719B 45.10
Teladoc Health (TDOC) United States $1.603B 0.00
Progyny (PGNY) United States $1.442B 29.19
Establishment Labs Holdings (ESTA) $1.270B 0.00
Embecta (EMBC) United States $1.192B 8.33
CareDx (CDNA) United States $1.136B 0.00
Pediatrix Medical (MD) United States $1.134B 11.10
AMN Healthcare Services Inc (AMN) United States $0.907B 6.14
Agilon Health (AGL) United States $0.787B 0.00
SBC Medicals (SBC) United States $0.582B 0.00
QDM (QDMI) Hong Kong, SAR China $0.566B 14.81
InnovAge Holding (INNV) United States $0.535B 0.00
Auna S.A (AUNA) Luxembourg $0.497B 0.00
DocGo (DCGO) United States $0.441B 16.61
Sonida Senior Living (SNDA) United States $0.434B 0.00
Enhabit (EHAB) United States $0.387B 33.44
Sera Prognostics (SERA) United States $0.282B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.257B 0.00
MultiPlan (MPLN) United States $0.250B 0.00
Performant Healthcare (PHLT) United States $0.235B 0.00
LifeMD (LFMD) United States $0.222B 0.00
Biodesix (BDSX) United States $0.212B 0.00
Beauty Health (SKIN) United States $0.199B 0.00
Nutex Health (NUTX) United States $0.169B 0.00
ModivCare (MODV) United States $0.149B 8.09
So-Young (SY) China $0.092B 15.60
Ascend Wellness Holdings (AAWH) United States $0.077B 0.00
NeueHealth (NEUE) United States $0.061B 1.62
IceCure Medical (ICCM) Israel $0.050B 0.00
Singular Genomics Systems (OMIC) United States $0.049B 0.00
OncoCyte (OCX) United States $0.041B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.025B 0.00
Oncology Institute (TOI) United States $0.024B 0.00
Co-Diagnostics (CODX) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00